Genknowme offers epigenetic blood tests that measure biological age and the impact of chronic stress, now reimbursed by the insurer KPT. The start-up raised CHF 500,000 earlier this year from an unnamed strategic investor.
- Announced on
- Round
- Undisclosed round
- Amount
- CHF 500,000
- Location
- Lausanne, canton of Vaud
- Sector
- Health & medtech
Investors
The investors were not named in the announcement.
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic